Prospective evaluation of intravitreal bevacizumab for ischemic central retinal vein occlusion

Table 1 Demographic and clinical characteristics

Eye no.	Gender	Ethnicity	Age, years	Duration of symptoms, months	Visual acuity baseline, logMAR	Visual acuity at 6 months, logMAR	CFT baseline, μm	CFT at 6 months, μm	CCT baseline, μm	CCT at 6 months, μm
1	Male	White	50	2	1.3	HM	839	241	235	173
2	Female	Black	58	1	1.7	1.7	1128	414	359	276
3	Male	White	64	2	1.3	1.7	317	400	251	177
4	Female	White	78	6	HM	NLP	1033	235	235	164
5	Male	Hispanic	48	2	1.3	1.7	726	242	302	188
6	Female	White	63	4	1.3	1.7	527	163	330	306
7	Male	Hispanic	44	1	1.7	1.7	1136	150	294	212
8	Female	Black	52	3	1.3	1.7	1261	240	268	256
9	Female	White	64	1	1	1.3	759	99	341	295

HM hand movements, NLP no light perception, CFT central foveal thickness, CCT central choroidal thickness

ISSN: 2056-9920